142 related articles for article (PubMed ID: 32479683)
1. Role of Platelet C-Type Lectin-Like Receptor 2 in Promoting Lung Metastasis in Osteosarcoma.
Ichikawa J; Ando T; Kawasaki T; Sasaki T; Shirai T; Tsukiji N; Kimura Y; Aoki K; Hayakawa K; Suzuki-Inoue K; Saitoh M; Haro H
J Bone Miner Res; 2020 Sep; 35(9):1738-1750. PubMed ID: 32479683
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
[TBL] [Abstract][Full Text] [Related]
3. Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.
Takagi S; Sato S; Oh-hara T; Takami M; Koike S; Mishima Y; Hatake K; Fujita N
PLoS One; 2013; 8(8):e73609. PubMed ID: 23991201
[TBL] [Abstract][Full Text] [Related]
4. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
[TBL] [Abstract][Full Text] [Related]
5. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
[TBL] [Abstract][Full Text] [Related]
6. Targeting Podoplanin for the Treatment of Osteosarcoma.
Takemoto A; Takagi S; Ukaji T; Gyobu N; Kakino M; Takami M; Kobayashi A; Lebel M; Kawaguchi T; Sugawara M; Tsuji-Takayama K; Ichihara K; Funauchi Y; Ae K; Matsumoto S; Sugiura Y; Takeuchi K; Noda T; Katayama R; Fujita N
Clin Cancer Res; 2022 Jun; 28(12):2633-2645. PubMed ID: 35381070
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation.
Chang CH; Chung CH; Hsu CC; Peng HC; Huang TF
J Thromb Haemost; 2014 Apr; 12(4):540-9. PubMed ID: 24479713
[TBL] [Abstract][Full Text] [Related]
8. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.
Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K
J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
[TBL] [Abstract][Full Text] [Related]
10. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
Sheng M; Sun R; Fu J; Lu G
BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor podoplanin: from discovery to drug development.
Takemoto A; Miyata K; Fujita N
Cancer Metastasis Rev; 2017 Jun; 36(2):225-234. PubMed ID: 28674748
[TBL] [Abstract][Full Text] [Related]
12. Anti-podoplanin Monoclonal Antibody LpMab-7 Detects Metastatic Lesions of Osteosarcoma.
Kaneko MK; Oki H; Ogasawara S; Takagi M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):154-61. PubMed ID: 26090592
[TBL] [Abstract][Full Text] [Related]
13. Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis.
Sekiguchi T; Takemoto A; Takagi S; Takatori K; Sato S; Takami M; Fujita N
Oncotarget; 2016 Jan; 7(4):3934-46. PubMed ID: 26684030
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
[TBL] [Abstract][Full Text] [Related]
15. Platelet CLEC-2 and podoplanin in cancer metastasis.
Lowe KL; Navarro-Nunez L; Watson SP
Thromb Res; 2012 Apr; 129 Suppl 1():S30-7. PubMed ID: 22682130
[TBL] [Abstract][Full Text] [Related]
16. Platelet CLEC-2: Roles Beyond Hemostasis.
Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse model.
Shirai T; Tsukiji N; Sasaki T; Oishi S; Yokomori R; Takano K; Suzuki-Inoue K
J Thromb Haemost; 2023 Nov; 21(11):3153-3165. PubMed ID: 37473844
[TBL] [Abstract][Full Text] [Related]
18. Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.
Kaneko MK; Abe S; Ogasawara S; Fujii Y; Yamada S; Murata T; Uchida H; Tahara H; Nishioka Y; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):25-29. PubMed ID: 28157429
[TBL] [Abstract][Full Text] [Related]
19. Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction.
Tsukiji N; Inoue O; Morimoto M; Tatsumi N; Nagatomo H; Ueta K; Shirai T; Sasaki T; Otake S; Tamura S; Tachibana T; Okabe M; Hirashima M; Ozaki Y; Suzuki-Inoue K
Blood; 2018 Sep; 132(11):1167-1179. PubMed ID: 29853539
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment.
Miyata K; Takagi S; Sato S; Morioka H; Shiba K; Minamisawa T; Takami M; Fujita N
Cancer Med; 2014 Dec; 3(6):1595-604. PubMed ID: 25132683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]